biotech is slow and coolUntil it's not.
This is what I would like to see:
Anti aging results that draw competitive interest from the big cats
Evidence of product launch with AbbVie 1067
Royalty rate disclosure with a sales forecast or some numbers showing up on the books.
Announcement of a pets deal
Announcement of a human diabetes deal
Announcement that the CEO will step aside and let a fully seasoned Biotech exec from a mid or large cap step in and sell the company, for what the science is really worth. NPV of all the aforementioned deals
All of this is possible theoretically speaking, with the science factually represented and as it stands.
We don't need to bone on about what the problem is, because we all heard it every day for last 2 years and there is nothing we can do about it.